Philosophical transactions of the Royal Society of London. Series B, Biological sciences

Changes in self-thinking and depression severity after one moderate dose of psilocybin in depressed patients

Updated

Abstract

A single moderate dose of psilocybin (0.215 mg kg-1) resulted in significant reductions in depressive symptoms in 37 individuals diagnosed with major depressive disorder.

  • Depressive symptoms were assessed using Beck's depression inventory and the Montgomery-Åsberg depression rating scale.
  • Two weeks after administration, participants receiving psilocybin showed a significant increase in positive self-concept compared to those receiving placebo.
  • Changes in self-concept were significantly correlated with reductions in depressive scores.
  • Neuroimaging indicated psilocybin altered caudate activation related to externally oriented attention, differing from placebo effects during self-referential processing.
  • Results suggest that alterations in self-referential processing and self-concept may occur alongside improvements in depressive symptoms.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free